Drug Abuse Treatment Market

Drug Abuse Treatment Market INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2016–2024
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Drug Abuse Treatment Market : Overview
In 2017, Indivior PLC received the U.S. Food and Drug Administration (FDA)
approval for its new SUBLOCADE (buprenorphine extended- release) injection for
subcutaneous use. SUBLOCADE is indicated for the treatment of moderate to
severe opioid use disorder. In 2016, Teva Pharmaceutical Industries Ltd. launched a
generic version of CAMPRAL1 (acamprosate calcium) delayed-release tablets, 333
mg in the U.S. market. This tablet is indicated for the treatment and maintenance of
abstinence from alcohol in patients with alcohol dependence.
In April 2018, Dr. Reddy's Laboratories received the U.S. Food and Drug
Administration (FDA) approval to launch generic version of Suboxone sublingual
film indicated for the treatment of drug addiction. Suboxone is a combination of
Buprenorphine and Naloxone, Dr. Reddy's Laboratories received approval for all
dosage forms 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Drug Abuse Treatment Market : Taxonomy
•
This report provides in-depth analysis of drug abuse treatment market and
provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR
%) for the forecast period (2018 – 2026), considering 2017, as the base year
•
•
It elucidates potential revenue opportunity across different segments and explains
attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints,
opportunities, new product launches or approval, regional outlook, and
competitive strategy adopted by leading players
Download Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/2011
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Drug Abuse Treatment Market : Key Players
●
●
●
●
●
●
●
●
●
●
Cipla Limited
Glenmark Pharmaceuticals
Pfizer Inc.
Mylan N.V.
Odyssey Pharmaceuticals Inc.
Lil' Drug Store Products Inc.
Indivior Plc.
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
British American Tobacco plc.
Get More Information@
https://www.coherentmarketinsights.com/market-insight/drug-abuse-treatment-market-2011
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting
organization focused on assisting its plethora of clients achieve transformational
growth by helping them make critical business decisions. We are headquartered in
India, with an office at the global financial capital in the U.S. Our client base
includes players from across all business verticals in over 150 countries worldwide.
We are uniquely positioned to help businesses around the globe deliver practical
and lasting results through various recommendations about operational
improvements, technologies, emerging market trends and new working methods.
We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We
meticulously study emerging trends across various industries at both the global and
regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE
SERVICES
© Coherent market Insights. All Rights Reserved
CUSTOMIZED
RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC
STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL
DIAGNOSTIC
MEDICAL DEVICES
MEDICAL
IMAGING
OUR CLIENTS








Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
HEALTHCARE IT
PHARMACEUTICAL
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per
Year
150+
Consulting Projects Till Date
125+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEAR
CH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
Clients Worldwide Per Year
110+
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

In 2017, Indivior PLC received the U.S. Food and Drug Administration (FDA) approval for its new SUBLOCADE (buprenorphine extended- release) injection for subcutaneous use. SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder.

Download Report